Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms

Cardiovascular Research

Volumn 37, Issue 2, 1998, Pages 381-404

  Schaub, Marcus C ^a   Hefti, Martin A ^a   Zuellig, Richard A ^a   Morano, Ingo ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Ca2+ sensitivity tension relation; Cardiac hypertrophy; Contractility; Cross bridge kinetics; Heart failure; Myosin heavy chain; Myosin light chain

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALC1 PROTEIN; ALC2 PROTEIN; ALPHA TROPOMYOSIN; ATRIAL MYOSIN; CALCIUM; HETERODIMER; HOMODIMER; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; MYOSIN II; MYOSIN LIGHT CHAIN; MYOSIN SUBFRAGMENT; TROPOMYOSIN; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; V1 MYOSIN; V3 MYOSIN; VENTRICULAR MYOSIN;

ACTIN FILAMENT; ACTIN MYOSIN INTERACTION; AMINO TERMINAL SEQUENCE; BETA ADRENERGIC STIMULATION; BINDING AFFINITY; CALCIUM CELL LEVEL; CARBOXY TERMINAL SEQUENCE; CARDIAC MUSCLE CELL; CELL VIABILITY; CROSS BRIDGE CYCLE; CYTOSOL; ENERGY RESOURCE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE OVEREXPRESSION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; KINETICS; MECHANICAL STIMULUS TEST; MUSCLE FIBRIL; MUSCLE TWITCH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REVIEW; SARCOMERE LENGTH; SLOW MUSCLE; STARLING LAW; WILD TYPE;

EID: 0000266364     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00258-7     Document Type: Review

References (185)

1. Peterson JN, Alpert NR. Time course of mechanical efficiency during afterloaded contractions in isolated cardiac muscle. Am J Physiol 1991;261 4 Suppl.:27-29.
2. Gibbs CL, Barclay CJ. Cardiac efficiency. Cardiovasc Res 1995;30:627-634.
3. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process?. Am J Med 1980;69:576-584.
4. van Bilsen M, Chien KR. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res 1993;27:1140-1149.
5. Schaub MC, Hefti MA, Harder BA, Eppenberger HM. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 1997; in press.
6. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 1994;75:23-32.
7. Glennon PE, Sugden PH, Poole-Wilson PA. Cellular mechanisms of cardiac hypertrophy. Br Heart J 1995;73:496-499.
8. Hefti MA, Harder BA, Eppenberger HM, Schaub MC. Hypertrophy in cultured cardiomyocytes, signaling pathways and phenotypes. J Mol Cell Cardiol 1997; in press.
9. Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 1993;261:50-58.
10. Holmes KC. The swinging lever-arm hypothesis of muscle contraction. Curr Biol 1997;7:R112-118.
11. Xie X, Harrison DH, Schlichting I, Sweet RM, Kalabokis VN, Szent-Gyorgyi AG, Cohen C. Structure of the regulatory domain of scallop myosin at 2.8 A? resolution. Nature 1994;368:306-312.
12. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 1995;92:3864-3868.
13. Sellers JR, Goodson HV. Motor proteins 2: myosin. Protein Profile 1995;2 12.:1323-1423.
14. Reedy MK, Holmes KC, Tregear RT. Induced changes in orientation of the cross-bridges of glycerinated insect flight muscle. Nature 1965;207:1276-1280.
15. Huxley HE. The mechanism of muscular contraction. Science 1969;164:1356-1365.
16. Bordas J, Diakun GP, Diaz FG, Harries JE, Lewis RA, Lowy J, Mant GR, Martin-Fernandez ML, Towns-Andrews E. Two-dimensional time-resolved X-ray diffraction studies of live isometrically contracting frog sartorius muscle. J Muscle Res Cell Motil 1993;14:311-324.
17. Irving M, St. Claire Allen T, Sabido-David C, Craik JS, Brandmeier B, Kendrick-Jones J, Corrie JE, Trentham DR, Goldman YE. Tilting of the light-chain region of myosin during step length changes and active force generation in skeletal muscle. Nature 1995;375:688-691.
18. Huxley AF, Simmons RM. Proposed mechanism of force generation in striated muscle. Nature 1971;233:533-538.
19. Cooke R. The mechanism of muscle contraction. CRC Crit Rev Biochem 1986;21:53-118.
20. Uyeda TQ, Abramson PD, Spudich JA. The neck region of the myosin motor domain acts as a lever arm to generate movement. Proc Natl Acad Sci USA 1996;93:4459-4464.
21. Finer JT, Simmons RM, Spudich JA. Single myosin molecule mechanics: piconewton forces and nanometre steps. Nature 1994;368:113-119.
22. Holmes KC, Popp D, Gebhard W, Kabsch W. Atomic model of the actin filament. Nature 1990;347:44-49.
23. Rayment I, Holden HM, Whittaker M, Yohn CB, Lorenz M, Holmes KC, Milligan RA. Structure of the actin-myosin complex and its implications for muscle contraction. Science 1993;261:58-65.
24. Milligan RA. Protein-protein interactions in the rigor actomyosin complex. Proc Natl Acad Sci USA 1996;93:21-26.
25. Uyeda TQ, Ruppel KM, Spudich JA. Enzymatic activities correlate with chimaeric substitutions at the actin-binding face of myosin. Nature 1994;368:567-569.
26. Spudich JA. How molecular motors work. Nature 1994;372:515-518.
27. Vikstrom KL, Leinwand LA. Contractile protein mutations and heart disease. Curr Opin Cell Biol 1996;8:97-105.
28. Matsuoka R, Beisel KW, Furutani M, Arai S, Takao A. Complete sequence of human cardiac alpha-myosin heavy chain gene and amino acid comparison to other myosins based on structural and functional differences. Am J Med Genet 1991;41:537-547.
29. Jaenicke T, Diederich KW, Haas W, Schleich J, Lichter P, Pfordt M, Bach A, Vosberg HP. The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. Genomics 1990;8:194-206.
30. McNally EM, Kraft R, Bravo-Zehnder M, Taylor DA, Leinwand LA. Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. J Mol Biol 1989;210:665-671.
31. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 1986;66:710-771.
32. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996;76:371-423.
33. Cuda G, Fananapazir L, Epstein ND, Sellers JR. The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil 1997;18:275-283.
34. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 1995;95:1409-1414.
35. Kawasaki H, Kretsinger RH. Calcium-binding proteins. 1: EF-hands. Protein Profile 1994;1 4.:343-517.
36. Watterson JG, Kohler L, Schaub MC. Evidence for two distinct affinities in the binding of divalent metal ions to myosin. J Biol Chem 1979;254:6470-6477.
37. Wagner PD, Giniger E. Hydrolysis of ATP and reversible binding to F-actin by myosin heavy chains free of all light chains. Nature 1981;292:560-562.
38. Sivaramakrishnan M, Burke M. The free heavy chain of vertebrate skeletal myosin subfragment 1 shows full enzymatic activity. J Biol Chem 1982;257:1102-1105.
39. Adelstein RS, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 1980;49:921-956.
40. Di Blasio B, Pavone V, Saviano M, Lombardi A, Nastri F, Pedone C, Benedetti E, Crisma M, Anzolin M, Toniolo C. Structural characterization of the beta-bend ribbon. Spiral crystallographic analysis of two long L-Pro-Aib-N sequential peptides. J Am Chem Soc 1992;114:6273-6278.
41. Sutoh K. Identification of myosin-binding sites on the actin sequence. Biochemistry 1982;21:3654-3661.
42. Trayer IP, Trayer HR, Levine BA. Evidence that the N-terminal region of A1-light chain of myosin interacts directly with the C-terminal region of actin. A proton magnetic resonance study. Eur J Biochem 1987;164:259-266.
43. Timson DJ, Trayer IP. The myosin essential light chain: how it fine tunes a protein machine. J Muscle Res Cell Motil 1997;18:260. Abstract.
44. Milligan RA, Whittaker M, Safer D. Molecular structure of F-actin and location of surface binding sites. Nature 1990;348:217-221.
45. Sweeney HL. Function of the N terminus of the myosin essential light chain of vertebrate striated muscle. Biophys J 1995;68-4 Suppl.:112S-118S. Discussion 118S-119S.
46. Sweeney HL, Holzbaur EL. Mutational analysis of motor proteins. Annu Rev Physiol 1996;58:751-792.
47. Timson DJ, Trayer IP. The role of the proline-rich region in A1-type myosin essential light chains: implications for information transmission in the actomyosin complex. FEBS Lett 1997;400:31-36.
48. Barton PJ, Robert B, Cohen A, Garner I, Sassoon D, Weydert A, Buckingham ME. Structure and sequence of the myosin alkali light chain gene expressed in adult cardiac atria and fetal striated muscle. J Biol Chem 1988;263:12669-12676.
49. Barton PJ, Cohen A, Robert B, Fiszman MY, Bonhomme F, Guenet JL, Leader DP, Buckingham ME. The myosin alkali light chains of mouse ventricular and slow skeletal muscle are indistinguishable and are encoded by the same gene. J Biol Chem 1985;260:8578-8584.
50. Price KM, Littler WA, Cummins P. Human atrial and ventricular myosin light-chains subunits in the adult and during development. Biochem J 1980;191:571-580.
51. Morano I, Arndt H, Gartner C, Ruegg JC. Skinned fibers of human atrium and ventricle: myosin isoenzymes and contractility. Circ Res 1988;62:632-639.
52. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 1985;25:593-620.
53. Morano I, Wankerl M, Bohm M, Erdmann E, Ruegg JC. Myosin P-light chain isoenzymes in the human heart: evidence for diphosphorylation of the atrial P-LC form. Basic Res Cardiol 1989;84:298-305.
54. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Gen 1996;13:63-69.
55. Bouvagnet P, Leger J, Dechesne CA, Dureau G, Anoal M, Leger JJ. Local changes in myosin types in diseased human atrial myocardium: a quantitative immunofluorescence study. Circulation 1985;72:272-279.
56. Buttrick PM, Malhotra A, Brodman R, McDermott L, Lam L. Myosin isoenzyme distribution in overloaded human atrial tissue. Circulation 1986;74:477-483.
57. Cummins P, Lambert SJ. Myosin transitions in the bovine and human heart. A developmental and anatomical study of heavy and light chain subunits in the atrium and ventricle. Circ Res 1986;58:846-858.
58. Cummins P. Contractile protein transitions in human cardiac over-load: reality and limitations. Eur Heart J 1984;5 Suppl F.:119-127.
59. Gorza L, Mercadier JJ, Schwartz K, Thornell LE, Sartore S, Schiaffino S. Myosin types in the human heart. An immunofluorescence study of normal and hypertrophied atrial and ventricular myocardium. Circ Res 1984;54:694-702.
60. Schwartz K, Apstein C, Mercadier JJ, Lecarpentier Y, de la Bastie D, Bouveret P, Wisnewsky C, Swynghedauw B. Left ventricular isomyosins in normal and hypertrophied rat and human hearts. Eur Heart J 1984;5 Suppl F.:77-83.
61. Yazaki Y, Tsuchimochi H, Kuro-o M, Kurabayashi M, Isobe M, Ueda S, Nagai R, Takaku F. Distribution of myosin isozymes in human atrial and ventricular myocardium: comparison in normal and overloaded heart. Eur Heart J 1984;5 Suppl F.:103-110.
62. Bouvagnet P, Mairhofer H, Leger JO, Puech P, Leger JJ. Distribution pattern of alpha and beta myosin in normal and diseased human ventricular myocardium. Basic Res Cardiol 1989;84:91-102.
63. Morano I, Hadicke K, Haase H, Bohm M, Erdmann E, Schaub M. Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failling human heart. J Mol Cell Cardiol 1997;29:1177-1187.
64. Cummins P. Transitions in human atrial and ventricular myosin light-chain isoenzymes in response to cardiac-pressure-overload-induced hypertrophy. Biochem J 1982;205:195-204.
65. Arndt H, Bletz C, Katus HA, Mall G, Ruegg JC. Calcium sensitivity and unloaded shortening velocity of hypertrophied and non-hypertrophied skinned human atrial fibres. Pflugers Arch 1989;415:209-213.
66. Wankerl M, Bohm M, Morano I, Ruegg JC, Eichhorn M, Erdmann E. Calcium sensitivity and myosin light chain pattern of atrial and ventricular skinned cardiac fibers from patients with various kinds of cardiac disease. J Mol Cell Cardiol 1990;22:1425-1438.
67. Schaub MC, Tuchschmid CR, Srihari T, Hirzel HO. Myosin isoenzymes in human hypertrophic hearts. Shift in atrial myosin heavy chains and in ventricular myosin light chains. Eur Heart J 1984;5Suppl F.:85-93.
68. Hirzel HO, Tuchschmid CR, Schneider J, Krayenbuehl HP, Schaub MC. Relationship between myosin isoenzyme composition, hemodynamics and myocardial structure in various forms of human cardiac hypertrophy. Circ Res 1985;57:729-740.
69. Sutsch G, Brunner UT, von Schulthess C, Hirzel HO, Hess OM, Turina M, Krayenbuehl HP, Schaub MC. Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Circ Res 1992;70:1035-1043.
70. Eppenberger ME, Hauser I, Baechi T, Schaub MC, Brunner UT, Dechesne CA, Eppenberger HM. Immunocytochemical analysis of the regeneration of myofibrils in long-term cultures of adult cardiomyocytes of the rat. Dev Biol 1988;130:1-15.
71. Henkel RD, Kammerer CM, Escobedo LV, VandeBerg JL, Walsh RA. Correlated expression of atrial myosin heavy chain and regulatory light chain isoforms with pressure overload hypertrophy in the non-human primate. Cardiovasc Res 1993;27:416-422.
72. Zak R. Metabolism of myofibrillar proteins in the normal and hypertrophic heart. Basic Res Cardiol 1977;72:235-240.
73. Martin AF. Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. J Biol Chem 1981;256:964-968.
74. Gulick J, Hewett TE, Klevitsky R, Buck SH, Moss RL, Robbins J. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res 1997;80:655-664.
75. Eisenberg E, Hill TL. Muscle contraction and free energy transduction in biological systems. Science 1985;227:999-1006.
76. Brenner B. The cross-bridge cycle in muscle. Mechanical, biochemical and structural studies on single skinned rabbit psoas fibers to characterize cross-bridge kinetics in muscle for correlation with the actomyosin-ATPase in solution. Basic Res Cardiol 1986;81 Suppl 1.:1-15.
77. Dantzig JA, Goldman YE, Millar NC, Lacktis J, Homsher E. Reversal of the cross-bridge force-generating transition by photogeneration of phosphate in rabbit psoas muscle fibres. J Physiol 1992;451:247-278.
78. Brenner B, Yu LC. Structural changes in the actomyosin crossbridges associated with force generation. Proc Natl Acad Sci USA 1993;90:5252-5256.
79. Moss RL, Diffee GM, Greaser ML. Contractile properties of skeletal muscle fibers in relation to myofibrillar protein isoforms. Rev Physiol Biochem Pharmacol 1995;126:1-63.
80. Huxley AF. Muscle structure and theories of cintraction. Prog Biophys Chem 1957;7:255-318.
81. Brenner B, Schoenberg M, Chalovich JM, Greene LE, Eisenberg E. Evidence for cross-bridge attachment in relaxed muscle at low ionic strength. Proc Natl Acad Sci USA 1982;79:7288-7291.
82. Brenner B. Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci USA 1988;85:3265-3269.
83. Siemankowski RF, Wiseman MO, White HD. ADP dissociation from actomyosin subfragment 1 is sufficiently slow to limit the unloaded shortening velocity in vertebrate muscle. Proc Natl Acad Sci USA 1985;82:658-662.
84. Marechal G, Beckers-Bleukx G. Force-velocity relation and isomyosins in soleus muscles from two strains of mice-C57 and NMRI. Pflugers Arch 1993;424:478-487.
85. Edman KAP. The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibres. J Physiol 1979;291:143-159.
86. Seow CY, Ford LE. Shortening velocity and power output of skinned muscle fibers from mammals having a 25,000-fold range of body mass. J Gen Physiol 1991;97:541-560.
87. Rome LC, Sosnicki AA, Goble DO. Maximum velocity of shortening of three fibre types from horse soleus muscle: implications for scaling with body size. J Physiol 1990;431:173-185.
88. Rome LC, Funke RP, Alexander RM, Lutz G, Aldridge H, Scott F, Freadman M. Why animals have different muscle fibre types. Nature 1988;335:824-827.
89. Bottinelli R, Schiaffino S, Reggiani C. Force-velocity relations and myosin heavy chain isoform compositions of skinned fibres from rat skeletal muscle. J Physiol 1991;437:655-672.
90. Barry WH, Bridge JH. Intracellular calcium homeostasis in cardiac myocytes. Circulation 1993;87:1806-1815.
91. Gao WD, Backx PH, Azan-Backx M, Marban E. Myofilament Ca2+ sensitivity in intact versus skinned rat ventricular muscle. Circ Res 1994;74:408-415.
92. Hill AV. The possible effects of the aggregation of the molecules and haemoglobin on its dissociation curves. Nature 1910;40:4-7.
93. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 1996;58:447-481.
94. Ruegg JC. Calcium in Muscle Contraction, 2nd edn. Berlin: Springer Verlag 1992.
95. Parmacek MS, Leiden JM. Structure, function and regulation of troponin C. Circulation 1991;84:991-1003.
96. Morano I, Bletz C, Wojciechowski R, Ruegg JC. Modulation of crossbridge kinetics by myosin isoenzymes in skinned human heart fibers. Circ Res 1991;68:614-618.
97. Morano I, Osterman A, Arner A. Rate of active tension development from rigor in skinned atrial and ventricular cardiac fibres from swine following photolytic release of ATP from caged ATP. Acta Physiol Scand 1995;154:343-353.
98. VanBuren P, Harris DE, Alpert NR, Warshaw DM. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ Res 1995;77:439-444.
99. Hasenfuss G, Mulieri LA, Blanchard EM, Holubarsch C, Leavitt BJ, Ittleman F, Alpert NR. Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. Circ Res 1991;68:836-846.
100. Harris DE, Work SS, Wright RK, Alpert NR, Warshaw DM. Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J Muscle Res Cell Motil 1994;15:11-19.
101. VanBuren P, Work SS, Warshaw DM. Enhanced force generation by smooth muscle myosin in vitro. Proc Natl Acad Sci USA 1994;91:202-205.
102. Bottinelli R, Canepari M, Cappelli V, Reggiani C. Maximum speed of shortening and ATPase activity in atrial and ventricular myocardia of hyperthyroid rats. Am J Physiol 1995;269:C785-790.
103. Lowey S, Trybus KM. Role of skeletal and smooth muscle myosin light chains. Biophys J 1995;68-4 Suppl.:120S-126S.
104. Cummins P, Russell G. A comparison of myosin light chain subunits in the atria and ventricles of mammals. Comp Biochem Physiol wBx 1986;84:343-348.
105. Schwinger RH, Bohm M, Koch A, Schmidt U, Morano I, Eissner HJ, Uberfuhr P, Reichart B, Erdmann E. The failing human heart is unable to use the Frank-Starling mechanism. Circ Res 1994;74:959-969.
106. Auckland LM, Lambert SJ, Cummins P. Cardiac myosin light and heavy chain isotypes in tetralogy of Fallot. Cardiovasc Res 1986;20:828-836.
107. Morano M, Zacharzowski U, Maier M, Lange PE, Alexi-Meskishvili V, Haase H, Morano I. Regulation of human heart contractility by essential myosin light chain isoforms. J Clin Invest 1996;98:467-473.
108. Periasamy M, Strehler EE, Garfinkel LI, Gubits RM, Ruiz-Opazo N, Nadal-Ginard B. Fast skeletal muscle myosin light chains 1 and 3 are produced from a single gene by a combined process of differential RNA transcription and splicing. J Biol Chem 1984;259:13595-13604.
109. Lowey S, Waller GS, Trybus KM. Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature 1993;365:454-456.
110. Hayashibara T, Miyanishi T. Binding of the amino-terminal region of myosin alkali 1 light chain to actin and its effect on actin-myosin interaction. Biochemistry 1994;33:12821-12827.
111. Henry GD, Trayer IP, Brewer S, Levine BA. The widespread distribution of alpha-N-trimethylalanine as the N-terminal amino acid of light chains from vertebrate striated muscle myosins. Eur J Biochem 1985;148:75-82.
112. Morano I, Haase H. Different actin affinities of human cardiac essential myosin light chain isoforms. FEBS Lett 1997;408:71-74.
113. Morano I, Ritter O, Bonz A, Timek T, Vahl CF, Michel G. Myosin light chain-actin interaction regulates cardiac contractility. Circ Res 1995;76:720-725.
114. Rarick HM, Opgenorth TJ, Vongeldern TW, Wuwong JSR, Solaro RJ. An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar atpase activity. J Biol Chem 1996;271:27039-27043.
115. Williamson MP. The structure and function of proline-rich regions in proteins. Biochem J 1994;297:249-260.
116. Atar D, Gao WD, Marban E. Alterations of excitation-contraction coupling in stunned myocardium and in failing myocardium. J Mol Cell Cardiol 1995;27:783-791.
117. Nakao K, Yasue H, Fujimoto K, Jougasaki M, Yamamoto H, Hitoshi Y, Takatsu K, Miyamoto E. Increased expression and regional differences of atrial myosin light chain 1 in human ventricles with old myocardial infarction. Analyses using two monoclonal antibodies. Circulation 1992;86:1727-1737.
118. Fujimoto K, Yasue H, Nakao K, Yamamoto H, Hitoshi Y, Jougasaki M, Okumura K, Ogawa H, Takatsu K, Miyamoto E. Novel monoclonal antibodies specific for human cardiac myosin light-chain 1: useful tools for analysis of normal and pathological hearts. J Histochem Cytochem 1993;41:35-42.
119. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G, et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995;92:778-784.
120. Studer R, Reinecke H, Bilger J, Eschenhagen T, Bohm M, Hasenfuss G, Just H, Holtz J, Drexler H. Gene expression of the cardiac Na-q.-Ca2+ exchanger in end-stage human heart failure. Circ Res 1994;75:443-453.
121. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85:1046-1055.
122. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation 1992;85:1743-1750.
123. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 1995;92:1169-1178.
124. Pieske B, Sutterlin M, Schmidt-Schweda S, Minami K, Meyer M, Olschewski M, Holubarsch C, Just H, Hasenfuss G. Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling. J Clin Invest 1996;98:764-776.
125. Mulieri LA, Leavitt BJ, Hasenfuss G, Allen PD, Alpert NR. Contraction frequency dependence of twitch and diastolic tension in human dilated cardiomyopathy-tension-frequency relation in cardiomyopathy. Basic Res Cardiol 1992;87 Suppl 1.:199-212.
126. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997;276:800-806.
127. Bristow MR, Feldman AM. Changes in the receptor-G proteinadenylyl cyclase system in heart failure from various types of heart muscle disease. Basic Res Cardiol 1992;87-Suppl 1.:15-35.
128. Winegrad S. Endothelial cell regulation of contractility of the heart. Annu Rev Physiol 1997;59:505-525.
129. Shah AM, Mebazaa A, Yang ZK, Cuda G, Lankford EB, Pepper CB, Sollott SJ, Sellers JR, Robotham JL, Lakatta EG. Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells-a potential mechanism for matching oxygen supply and demand. Circ Res 1997;80:688-698.
130. Heusch G, Schulz R. Hibernating myocardium: a review. J Mol Cell Cardiol 1996;28:2359-2372.
131. Shivalkar B, Maes A, Borgers M, Ausma J, Scheys I, Nuyts J, Mortelmans L, Flameng W. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation 1996;94:308-315.
132. Schramm M, Klieber HG, Daut J. The energy expenditure of actomyosin-ATPase, Ca-2q .-ATPase and Naq,K-q.-ATPase in guinea-pig cardiac ventricular muscle. J Physiol-Lond. 1994;481:647-662.
133. Marban E, Kitakaze M, Koretsune Y, Yue DT, Chacko VP, Pike MM. Quantification of wCa2+ xi in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res 1990;66:1255-1267.
134. Mellgren RL. Proteolysis of nuclear proteins by mu-calpain and m-calpain. J Biol Chem 1991;266:13920-13924.
135. Labeit S, Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 1995;27:293-296.
136. Morano I, Hadicke K, Grom S, Koch A, Schwinger RH, Bohm M, Bartel S, Erdmann E, Krause EG. Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol 1994;26:361-368.
137. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-514.
138. Hein S, Scholz D, Fujitani N, Rennollet H, Brand T, Friedl A, Schaper J. Altered expression of titin and contractile proteins in failing human myocardium. J Mol Cell Cardiol 1994;26:1291-1306.
139. Ausma J, Furst D, Thone F, Shivalkar B, Flameng W, Weber K, Ramaekers F, Borgers M. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation. J Mol Cell Cardiol 1995;27:1203-1212.
140. Margossian SS, White HD, Caulfield JB, Norton P, Taylor S, Slayter HS. Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy. Identification of a causal agent for impaired myocardial function. Circulation 1992;85:1720-1733.
141. Hofmann PA, Metzger JM, Greaser ML, Moss RL. Effects of partial extraction of light chain 2 on the Ca2+ sensitivities of isometric tension, stiffness and velocity of shortening in skinned skeletal muscle fibers. J Gen Physiol 1990;95:477-498.
142. Szczesna D, Zhao J, Potter JD. The regulatory light chains of myosin modulate cross-bridge cycling in skeletal muscle. J Biol Chem 1996;271:5246-5250.
143. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 1997;80:393-399.
144. Cooper TA, Ordahl CP. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J Biol Chem 1985;260:11140-11148.
145. Mesnard L, Logeart D, Taviaux S, Diriong S, Mercadier JJ, Samson F. Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart. Circ Res 1995;76:687-692.
146. Anderson PA, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 1995;76:681-686.
147. Townsend PJ, Barton PJ, Yacoub MH, Farza H. Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J Mol Cell Cardiol 1995;27:2223-2236.
148. Anderson PA, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart and adult and fetal skeletal muscle. Circ Res 1991;69:1226-1233.
149. Nassar R, Malouf NN, Kelly MB, Oakeley AE, Anderson PA. Force-pCa relation and troponin T isoforms of rabbit myocardium. Circ Res 1991;69:1470-1475.
150. Akella AB, Ding XL, Cheng R, Gulati J. Diminished Ca2+ sensitivity of skinned cardiac muscle contractility coincident with troponin T-band shifts in the diabetic rat. Circ Res 1995;76:600-606.
151. Hunkeler NM, Kullman J, Murphy AM. Troponin I isoform expression in human heart. Circ Res 1991;69:1409-1414.
152. Martin AF, Ball K, Gao LZ, Kumar P, Solaro RJ. Identification and functional significance of troponin I isoforms in neonatal rat heart myofibrils. Circ Res 1991;69:1244-1252.
153. Gahlmann R, Wade R, Gunning P, Kedes L. Differential expression of slow and fast skeletal muscle troponin C. Slow skeletal muscle troponin C is expressed in human fibroblasts. J Mol Biol 1988;201:379-391.
154. Moss RL, Lauer MR, Giulian GG, Greaser ML. Altered Ca2+ dependence of tension development in skinned skeletal muscle fibers following modification of troponin by partial substitution with cardiac troponin C. J Biol Chem 1986;261:6096-6099.
155. Hewett TE, Grupp IL, Grupp G, Robbins J. Alpha-skeletal actin is associated with increased contractility in the mouse heart. Circ Res 1994;74:740-746.
156. Boheler KR, Carrier L, de la Bastie D, Allen PD, Komajda M, Mercadier JJ, Schwartz K. Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts. J Clin Invest 1991;88:323-330.
157. Palmiter KA, Kitada Y, Muthuchamy M, Wieczorek DF, Solaro RJ. Exchange of beta-for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding and protein phosphorylation. J Biol Chem 1996;271:11611-11614.
158. Zhi G, Herring BP, Stull JT. Structural requirements for phosphorylation of myosin regulatory light chain from smooth muscle. J Biol Chem 1994;269:24723-24727.
159. Noland TA Jr., Kuo JF. Phosphorylation of cardiac myosin light chain 2 by protein kinase C and myosin light chain kinase increases Ca-2q .-stimulated actomyosin MgATPase activity. Biochem Biophys Res Commun 1993;193:254-260.
160. Morano I, Hofmann F, Zimmer M, Ruegg JC. The influence of P-light chain phosphorylation by myosin light chain kinase on the calcium sensitivity of chemically skinned heart fibres. FEBS Lett 1985;189:221-224.
161. Morano I, Bachle-Stolz C, Katus A, Ruegg JC. Increased calcium sensitivity of chemically skinned human atria by myosin light chain kinase. Basic Res Cardiol 1988;83:350-359.
162. Morano I, Rosch J, Arner A, Ruegg JC. Phosphorylation and thiophosphorylation by myosin light chain kinase: different effects on mechanical properties of chemically skinned ventricular fibers from the pig. J Mol Cell Cardiol 1990;22:805-813.
163. Clement O, Puceat M, Walsh MP, Vassort G. Protein kinase C enhances myosin light-chain kinase effects on force development and ATPase activity in rat single skinned cardiac cells. Biochem J 1992;285:311-317.
164. Zhang R, Zhao J, Potter JD. Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C. J Biol Chem 1995;270:30773-30780.
165. Bhavsar PK, Brand NJ, Yacoub MH, Barton PJR. Isolation and characterization of the human cardiac troponin I gene-TNNI3. Genomics 1996;35:11-23.
166. Reiffert SU, Jaquet K, Heilmeyer LM Jr., Ritchie MD, Geeves MA. Bisphosphorylation of cardiac troponin I modulates the Ca-2q .-dependent binding of myosin subfragment S1 to reconstituted thin filaments. FEBS Lett 1996;384:43-47.
167. Noland TA Jr., Raynor RL, Jideama NM, Guo X, Kazanietz MG, Blumberg PM, Solaro RJ, Kuo JF. Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozymespecific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry 1996;35:14923-14931.
168. Heeley DH. Investigation of the effects of phosphorylation of rabbit striated muscle alpha alpha-tropomyosin and rabbit skeletal muscle troponin-T. Eur J Biochem 1994;221:129-137.
169. deBelle I, Mak AS. Isolation and characterization of tropomyosin kinase from chicken embryo. Biochim Biophys Acta 1987;925:17-26.
170. Weisberg A, Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci USA 1996;93:8999-9003.
171. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?. Embo J 1995;14:1952-1960.
172. Venema RC, Kuo JF. Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase. J Biol Chem 1993;268:2705-2711.
173. Wattanapermpool J, Reiser PJ, Solaro RJ. Troponin I isoforms and differential effects of acidic pH on soleus and cardiac myofilaments. Am J Physiol 1995;268:C323-330.
174. Allen DG, Morris PG, Orchard CH, Pirolo JS. A nuclear magnetic resonance study of metabolism in the ferret heart during hypoxia and inhibition of glycolysis. J Physiol Lond. 1985;361:185-204.
175. Allen DG, Orchard CH. Intracellular calcium concentration during hypoxia and metabolic inhibition in mammalian ventricular muscle. J Physiol Lond. 1983;339:107-122.
176. Kentish JC. The effects of inorganic phosphate and creatine phosphate on force production in skinned muscles from rat ventricle. J Physiol Lond. 1986;370:585-604.
177. McDonald KS, Field LJ, Parmacek MS, Soonpaa M, Leiden JM, Moss RL. Length dependence of Ca2+ sensitivity of tension in mouse cardiac myocytes expressing skeletal troponin C. J Physiol Lond. 1995;483:131-139.
178. Fuchs F, Wang YP. Sarcomere length versus interfilament spacing as determinants of cardiac myofilament Ca2+ sensitivity and Ca2+ binding. J Mol Cell Cardiol 1996;28:1375-1383.
179. Akella AB, Su H, Sonnenblick EH, Rao VG, Gulati J. The cardiac troponin C isoform and the length dependence of Ca2+ sensitivity of tension in myocardium. J Mol Cell Cardiol 1997;29:381-389.
180. Holubarsch C, Ruf T, Goldstein DJ, Ashton RC, Nickl W, Pieske B, Pioch K, Ludemann J, Wiesner S, Hasenfuss G, Posival H, Just H, Burkhoff D. Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue and sarcomere levels. Circulation 1996;94:683-689.
181. Hofmann PA, Lange JH. Effects of phosphorylation of troponin I and C protein on isometric tension and velocity of unloaded shortening in skinned single cardiac myocytes from rats. Circ Res 1994;74:718-726.
182. Peppel K, Koch WJ, Lefkowitz RJ. Gene transfer strategies for augmenting cardiac function. Trends Cardiovasc Med 1997;7:145-150.
183. Carl SL, Felix K, Caswell AH, Brandt NR, Ball WJ Jr., Vaghy PL, Meissner G, Ferguson DG. Immunolocalization of sarcolemmal dihydropyridine receptor and sarcoplasmic reticular triadin and ryanodine receptor in rabbit ventricle and atrium. J Cell Biol 1995;129:672-682.
184. Sheterline P, Sparrow JC. Actin Protein Profile 1994;1-1.:1-121.
185. Jideama NM, Noland TA Jr., Raynor RL, Blobe GC, Fabbro D, Kazanietz MG, Blumberg PM, Hannun YA, Kuo JF. Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem 1996;271:23277-23283.